ValuEngine downgraded shares of Healthequity (NASDAQ:HQY) from a strong-buy rating to a buy rating in a research note released on Wednesday.

Several other brokerages have also recently commented on HQY. Raymond James lifted their price target on shares of Healthequity from $85.00 to $105.00 and gave the stock an outperform rating in a research report on Monday, September 10th. Bank of America cut shares of Healthequity from a buy rating to a neutral rating and lifted their price target for the stock from $84.00 to $105.00 in a research report on Thursday, September 6th. They noted that the move was a valuation call. Barrington Research reiterated an outperform rating and set a $100.00 price target on shares of Healthequity in a research report on Wednesday, September 5th. They noted that the move was a valuation call. SunTrust Banks lifted their price target on shares of Healthequity to $105.00 and gave the stock a buy rating in a research report on Wednesday, September 5th. Finally, Wells Fargo & Co boosted their price objective on shares of Healthequity from $84.00 to $105.00 and gave the company an outperform rating in a report on Wednesday, September 5th. Five research analysts have rated the stock with a hold rating and ten have issued a buy rating to the stock. The company has an average rating of Buy and a consensus target price of $92.08.

Shares of NASDAQ:HQY opened at $83.60 on Wednesday. Healthequity has a one year low of $42.92 and a one year high of $101.58. The company has a market cap of $5.19 billion, a PE ratio of 154.81, a price-to-earnings-growth ratio of 2.90 and a beta of 1.37.

Healthequity (NASDAQ:HQY) last issued its quarterly earnings results on Tuesday, December 4th. The company reported $0.22 EPS for the quarter, topping the consensus estimate of $0.20 by $0.02. Healthequity had a net margin of 24.52% and a return on equity of 12.93%. The company had revenue of $70.50 million during the quarter, compared to analysts’ expectations of $69.60 million. During the same quarter in the previous year, the company earned $0.17 EPS. Healthequity’s revenue was up 24.1% on a year-over-year basis. Research analysts expect that Healthequity will post 0.87 earnings per share for the current year.

In related news, VP Darcy G. Mott sold 4,000 shares of the business’s stock in a transaction that occurred on Monday, October 22nd. The shares were sold at an average price of $87.01, for a total transaction of $348,040.00. Following the completion of the transaction, the vice president now owns 92,500 shares in the company, valued at $8,048,425. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. In the last 90 days, insiders have sold 12,000 shares of company stock valued at $1,027,400. Corporate insiders own 4.00% of the company’s stock.

A number of institutional investors and hedge funds have recently made changes to their positions in HQY. Acadian Asset Management LLC bought a new position in Healthequity in the second quarter valued at approximately $845,000. Janney Montgomery Scott LLC lifted its stake in Healthequity by 73.7% in the second quarter. Janney Montgomery Scott LLC now owns 20,776 shares of the company’s stock valued at $1,560,000 after buying an additional 8,814 shares in the last quarter. Eqis Capital Management Inc. bought a new position in Healthequity in the second quarter valued at approximately $422,000. Aperio Group LLC lifted its position in shares of Healthequity by 6.3% in the second quarter. Aperio Group LLC now owns 17,977 shares of the company’s stock worth $1,350,000 after purchasing an additional 1,064 shares in the last quarter. Finally, Raymond James Financial Services Advisors Inc. lifted its position in shares of Healthequity by 16.9% in the second quarter. Raymond James Financial Services Advisors Inc. now owns 97,854 shares of the company’s stock worth $7,349,000 after purchasing an additional 14,131 shares in the last quarter. 93.01% of the stock is currently owned by hedge funds and other institutional investors.

Healthequity Company Profile

HealthEquity, Inc provides various solutions for managing health care accounts, health reimbursement arrangements, and flexible spending accounts for health plans, insurance companies, and third-party administrators in the United States. The company offers healthcare saving and spending platform, a cloud-based platform for individuals to make health saving and spending decisions, pay healthcare bills, compare treatment options and prices, receive personalized benefit and clinical information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.

Featured Article: Retained Earnings

To view ValuEngine’s full report, visit ValuEngine’s official website.

Analyst Recommendations for Healthequity (NASDAQ:HQY)

Receive News & Ratings for Healthequity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Healthequity and related companies with MarketBeat.com's FREE daily email newsletter.